These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3348466)

  • 21. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preinjury psychiatric illness and postinjury adjustment in adult burn survivors.
    Fauerbach JA; Lawrence J; Haythornthwaite J; McGuire M; Munster A
    Psychosomatics; 1996; 37(6):547-55. PubMed ID: 8942205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V.
    Watson D
    J Abnorm Psychol; 2005 Nov; 114(4):522-36. PubMed ID: 16351375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affective disorder and substance abuse in women with bulimia.
    Hatsukami D; Eckert E; Mitchell JE; Pyle R
    Psychol Med; 1984 Aug; 14(3):701-4. PubMed ID: 6593758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Under-recognition and under-treatment of DSM-IV classified mood and anxiety disorders among disability claimants.
    Cornelius B; van der Klink JJ; Brouwer S; Groothoff JW
    Disabil Rehabil; 2014; 36(14):1161-8. PubMed ID: 24024541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distress and fear disorders: an alternative empirically based taxonomy of the "mood" and "anxiety" disorders.
    Clark LA; Watson D
    Br J Psychiatry; 2006 Dec; 189():481-3. PubMed ID: 17139030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The DSM-III classification of affective disorders.
    Spitzer RL; Williams JB
    Acta Psychiatr Scand Suppl; 1983; 310():106-16. PubMed ID: 6582767
    [No Abstract]   [Full Text] [Related]  

  • 28. Moroccan national study on prevalence of mental disorders: a community-based epidemiological study.
    Kadri N; Agoub M; Assouab F; Tazi MA; Didouh A; Stewart R; Paes M; Toufiq J; Moussaoui D
    Acta Psychiatr Scand; 2010 Jan; 121(1):71-4. PubMed ID: 19681770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment.
    Anthenelli RM; Schuckit MA
    J Addict Dis; 1993; 12(3):73-87. PubMed ID: 8251547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder.
    Parker G; Fink M; Shorter E; Taylor MA; Akiskal H; Berrios G; Bolwig T; Brown WA; Carroll B; Healy D; Klein DF; Koukopoulos A; Michels R; Paris J; Rubin RT; Spitzer R; Swartz C
    Am J Psychiatry; 2010 Jul; 167(7):745-7. PubMed ID: 20595426
    [No Abstract]   [Full Text] [Related]  

  • 31. Convergence of DSM-III diagnoses and self-reported symptoms in child and adolescent inpatients.
    Weinstein SR; Noam GG; Grimes K; Stone K; Schwab-Stone M
    J Am Acad Child Adolesc Psychiatry; 1990 Jul; 29(4):627-34. PubMed ID: 2387799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder.
    Grilo CM; White MA; Masheb RM
    Int J Eat Disord; 2009 Apr; 42(3):228-34. PubMed ID: 18951458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Substance-related and addictive disorders in the DSM-5].
    Thomasius R; Sack PM; Strittmatter E; Kaess M
    Z Kinder Jugendpsychiatr Psychother; 2014 Mar; 42(2):115-20. PubMed ID: 24571817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Co-occuring mood and substance use disorders].
    Adida M; Kaladjian A; Fakra E; Belzeaux R; Azorin JM
    Encephale; 2014 Dec; 40 Suppl 3():S8-S13. PubMed ID: 25550243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis of affective disorders in DSM-5: changes and controversies].
    Klein JP; Willenborg B; Schweiger U
    Fortschr Neurol Psychiatr; 2014 Nov; 82(11):655-63; quiz 664. PubMed ID: 25383933
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucocorticoids induced neuropsychiatric disorders].
    Cornic F; Rousset I
    Rev Prat; 2008 Mar; 58(5):469-75. PubMed ID: 18524099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spectrum of mood disorders.
    Lopez-Ibor JJ
    J Clin Psychiatry; 1990 Sep; 51 Suppl():62-4. PubMed ID: 2211572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The illustrated depression scale, an innovative tool].
    Salamin V; Mercier A
    Soins Psychiatr; 2013; (286):39-42. PubMed ID: 23757894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood disorders: review of current diagnostic systems.
    Paykel ES
    Psychopathology; 2002; 35(2-3):94-9. PubMed ID: 12145491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.